InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Sawhney Roger, Chief Financial Officer. Insider active across 1 company, notably Omega Therapeutics, Inc.. Cumulatively, 2 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €84k. Activity tracked since 3 August 2021. The latest transaction was filed on 3 August 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Roger Sawhney serves as the Chief Financial Officer of Omega Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial analysis. His expertise contributes to informed decision-making to support the company's growth and innovation.